Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
- PMID: 20049172
- PMCID: PMC2798671
- DOI: 10.1155/2010/821717
Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
Abstract
We focus on unique roles of miR-200c in breast, ovarian, and endometrial cancers. Members of the miR-200 family target ZEB1, a transcription factor which represses E-cadherin and other genes involved in polarity. We demonstrate that the double negative feedback loop between miR-200c and ZEB1 is functional in some, but not all cell lines. Restoration of miR-200c to aggressive cancer cells causes a decrease in migration and invasion. These effects are independent of E-cadherin status. Additionally, we observe that restoration of miR-200c to ovarian cancer cells causes a decrease in adhesion to laminin. We have previously reported that reintroduction of miR-200c to aggressive cells that lack miR-200c expression restores sensitivity to paclitaxel. We now prove that this ability is a result of direct targeting of class III beta-tubulin (TUBB3). Introduction of a TUBB3 expression construct lacking the miR-200c target site into cells transfected with miR-200c mimic results in no change in sensitivity to paclitaxel. Lastly, we observe a decrease in proliferation in cells transfected with miR-200c mimic, and cells where ZEB1 is knocked down stably, demonstrating that the ability of miR-200c to enhance sensitivity to paclitaxel is not due to an increased proliferation rate.
Figures
References
-
- Sempere LF, Christensen M, Silahtaroglu A, et al. Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Research. 2007;67(24):11612–11620. - PubMed
-
- Cowland JB, Hother C, Gronbaek K. MicroRNAs and cancer. Acta Pathologica, Microbiologica et Immunologica Scandinavica. 2007;115(10):1090–1106. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
